Altuviiio Children's Study Demonstrates Equivalent Outcomes
A yearlong study of the newly approved half-life extender showed no evidence of factor VIII inhibitors.
Source: managedhealthcareexecutive.com
Stay updated with breaking news from Weekly Factor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A yearlong study of the newly approved half-life extender showed no evidence of factor VIII inhibitors.